| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Principal repayments on finance leases | 251,272 | 193,241 |
| Net cash provided by financing activities | 13,393,750 | 4,050,738 |
| Net increase (decrease) in cash and cash equivalents | 6,563,904 | -302,456 |
| Cash and cash equivalents at beginning of period | 1,105,291 | - |
| Cash and cash equivalents at end of period | 7,669,195 | - |
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)